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FUNCTIONAL DATA ANALYTIC APPROACH OF MODELING
ECG T-WAVE SHAPE TO MEASURE CARDIOVASCULAR
BEHAVIOR1
By Yingchun Zhou and Nell Sedransk
East China Normal University and National Institute of Statistical Sciences
The T-wave of an electrocardiogram (ECG) represents the ven-
tricular repolarization that is critical in restoration of the heart mus-
cle to a pre-contractile state prior to the next beat. Alterations in the
T-wave reflect various cardiac conditions; and links between abnor-
mal (prolonged) ventricular repolarization and malignant arrhyth-
mias have been documented. Cardiac safety testing prior to approval
of any new drug currently relies on two points of the ECG waveform:
onset of the Q-wave and termination of the T-wave; and only a few
beats are measured. Using functional data analysis, a statistical ap-
proach extracts a common shape for each subject (reference curve)
from a sequence of beats, and then models the deviation of each curve
in the sequence from that reference curve as a four-dimensional vec-
tor. The representation can be used to distinguish differences between
beats or to model shape changes in a subject’s T-wave over time. This
model provides physically interpretable parameters characterizing T-
wave shape, and is robust to the determination of the endpoint of
the T-wave. Thus, this dimension reduction methodology offers the
strong potential for definition of more robust and more informative
biomarkers of cardiac abnormalities than the QT (or QT corrected)
interval in current use.
1. Introduction. Electrocardiograms (ECGs) are widely used to screen
and monitor the cardiac function of patients; and the behavior of the ECG
wave form is a basis for diagnosis of specific abnormalities. Important wave
forms of an ECG are marked by P, Q, R, S, T, as illustrated in Figure
1; these represent the changes in electrical potential as the heart contracts
and relaxes. The T-wave represents the repolarization (or post-contractile
phase) of the ventricles; and it is generally the most labile wave in the
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Fig. 1. Features of a normal ECG.
ECG. Abnormalities in the T-wave may be physiologic or may be externally
induced, for example, by cardio-active drugs.
The link between cardiac repolarization abnormalities and malignant ar-
rhythmias, especially torsades de pointes (TdP), which may degenerate
into ventricular fibrillation leading to sudden death, is well documented.
Since some drugs, for example, haloperidol [FDA (2007)] and terfenadine
[Morganroth, Brown and Critz (1993)], have been shown to cause repolar-
ization abnormalities, testing for cardiac safety is required as a part of every
new drug application to the FDA; and the FDA places very stringent con-
straints on the allowable prolongation of the repolarization process.
The current measure for cardiac safety that is used in drug development
and drug approval is prolongation of the QT interval. The premise for using
this measure is the evidence that the particular repolarization aberration,
TdP, is either preceded by or characterized by a pro-arrhythmia defined in
terms of delayed termination of the T-wave; more recently increased het-
Fig. 2. Two cardiologists’ marks of T-wave ends for 3 beats in a QT Dataset. The
differences are 17 milliseconds (a), 15 milliseconds (b) and 104 milliseconds (c).
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erogeneity of T-waves has also been implicated [Couderc et al. (2009)]. The
QT interval was first put forward in the 1920s and has been in continual
use since, with little modification and with cardiologists personally marking
the two critical points on the ECG: the initiation of the Q-wave and the
termination of the T-wave. From a practical point of view, in a normal ECG
of good quality, there is relatively little difficulty in the determination of the
onset of the Q-wave even though an ECG has no actual “baseline.” However,
measurement of the QT interval also relies on accurate and reproducible de-
termination of the endpoint of the T-wave, which is a greater challenge, as
can be seen from Figure 2. The differences between two cardiologists’ marks
are 17 milliseconds in (a), 15 milliseconds in (b) and 104 milliseconds in (c).
For QT analyses presented to the FDA, exceedance of 10 milliseconds for
the maximal time difference between drug and control over all time points
for a single patient calls into question the cardiac safety, requiring further
discussion, at the least, before considering approval of the drug.
Thus, weaknesses of the current measurement method are four-fold: (1)
QT as a cardiac safety indicator is predicated on detecting a heart-rhythm
change associated (but not exclusively) with a particular cardiac arrhyth-
mia. Slow trends, abrupt shifts in T-wave morphology, early precursors for
T-wave changes and/or episodic events are not necessarily reflected. (2) The
measurement ignores the information in the shape of the curve (the T-wave
morphology), relying instead upon only two points of the complex curve.
(3) Accuracy and the reproducibility of the measurement based on the end-
point of the T-wave depend on the sharpness of the T-wave form. (4) Current
measurement practice calls for measuring and then averaging a sequence of
a few (usually three) “highly similar” beats, most often from a 10-second
record. (This 10-second sequence is often preselected by an algorithm that
excludes difficult-to-read “outlier” beats and then captures a sequence for a
near-constant heart rate, following 90 seconds of minuscule heart-rate varia-
tion. In this case, the cardiologist does not see the complete ECG, but only
the selected beat sequence.)
In this paper a statistical model of the T-wave shape is constructed based
on function data analysis (FDA), using all the data in an extended (minutes
or longer) ECG record. This model has four interpretable parameters and
performs well in describing both normal and arrhythmia ECGs available
in public libraries. Because the parametrization of the model accounts for
the morphology of the entire T-wave, it is particularly useful for describing
changes in the repolarization process. It also has the significant advantage
that it is robust to the determination of the onset or the end of the T-wave.
Effectively, this functional data analysis approach decomposes a sequence
of T-waves for an individual subject into a reference curve (representing the
common shape of the T-waves) and a four-dimensional representation of the
deviation of each individual T-wave in the sequence. Inference about changes
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in cardiac function within the sequence can now be analyzed through the
four-dimensional representation of individual T-waves. For multiple ECG
sequences for the same subject, the reference curves for the individual se-
quences can be treated as data to again be analyzed by the appropriate
construction of a (superpopulation) hyper-reference curve (representing the
common shape of the reference curves) and four-dimensional representations
of the “hyper-deviations” of each reference curve from the hyper-curve. In
this fashion, the hyper-deviations can be used to analyze longer scale pro-
cesses such as diurnal effects or shifts in baseline ECGs for long-term exper-
iments.
Alternative methods to model the shape of ECG waves including the T-
wave are principal component analysis (PCA) [Laguna et al. (1999)] and
Gaussian models [Clifford (2006)]. Both methods fit the wave forms quite
well and reduce the dimension of the data significantly. However, in terms of
interpretation of model parameters, neither of them does well. The principal
components and loadings in PCA do not provide physical interpretation of
ECGs. The location and scale parameters in a Gaussian model may reveal
some information about the shape of a T-wave, but they are not robust to
small changes in T-waves such as those caused by noise. These features are
shown in specific examples in Section 4.
The major difference between this FDA model and other models is that
this model has a common reference curve for all the beats in the sequence
and measures the deviation of each wave from the common curve. So it is
most useful when one wants to compare the wave shape of a sequence of
beats. All the other methods treat each wave separately, making it harder
to compare model parameters across beats.
The ECGs examined in this research were all taken under normal clin-
ical conditions and are digitized; they are in the public libraries through
physionet (www.physiotnet.org). These ECGs include both normal subjects
and subjects with various classes of arrhythmias and other cardiac func-
tion abnormalities; there are no data available (there or elsewhere) from
actual QT studies since this data is proprietary and is held securely by the
pharmaceutical companies.
Section 2 describes the preprocessing of a sample of the digitized ECG
data before feeding it to the model, and lays out a general data structure
to be studied. Section 3 describes the basic model, illustrates model robust-
ness to the marking of T-wave boundaries, and shows the relation of model
parameters to QT. In Section 4 statistical inference is shown on how to ap-
ply the model to T-wave analysis. Further issues and potential extension
regarding the model and its applications are discussed on Section 5. Section
6 summarizes the conclusions from this research.
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2. Description of data.
2.1. One sample of ECG series. ECG data consist of a series of digitized
waveforms, where the digitized value is the intensity of electrical potential
(in millivolts) usually taken at a rate of 250 Hz (1 point per 4 milliseconds)
or 1000 Hz (1 point per millisecond).
In order to make full use of the complete ECG record and to understand
the natural variation of the T-wave over time, a natural representation is
given by “stacking” aligned ECG segments of consecutive beats within a
sample. To study the morphology of the T-wave, the stacked beats are left-
and right-truncated uniformly, retaining the entire T-wave to form an I × J
matrix X = [x1, . . . , xI ]
T , where xi = [xit1 , . . . , xitJ ] is the digitized value of
T-wave during the interval of the ith beat and I is the number of total beats
in this record. Beats are aligned according to their QRS complexes since this
complex is the most remarkable feature of ECG, and it allows the easiest and
least variable alignment. While there are various methods for choosing the
beginning and the end of T-waves, for example, the threshold method and
the slope method [Panicker et al. (2006)], for the purpose of this study, the
beginning and end points of the stacked T-waves are chosen to be identical
for all the T-waves and to visually capture the shape of the T-waves. As will
be shown later, the method described in this paper is robust to the choice
of the beginning and end points. Having the beginning and end points equal
for all beats is convenient for data analysis.
2.2. General data structure. A general data structure includes three lev-
els: beat, sample and subject, one nested within another. In a typical study
there are P subjects, each subject has Qp samples, and each sample has Ipq
beats. Each beat has Jpq time points within the T-wave interval. The data
structure and notation is as follows:
• Subject p, p= 1, . . . , P .
• Sample q (nested within subject p), q = 1, . . . ,Qp.
• Beat i (nested within subject p and sample q), i= 1, . . . , Ipq.
• Time point tj , j = 1, . . . , Jpq.
• Digitized value xitj , i= 1, . . . , Ipq, j = 1, . . . , Jpq.
Note that all the data we use in this paper are digitized ECG data from
PhysioNet (www.physionet.org), a public research resource website for phys-
iologic signals. The sampling frequency is 250 Hz (250 points per second).
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3. T-wave modeling using functional data analysis.
3.1. A model based on modes of variation of functional data. Consider
the data matrix X for a sample ECG. Although X involves only discrete
values, it reflects smooth curves of T-waves that generate these values. As
explained by Ramsay and Silverman [Ramsay and Silverman (1997)], this
data matrix can be viewed as functional data since each row is a function
of the time points at which they are measured, and these functions together
form a family of functions. The goal here is to characterize each function in
this family and to measure their variation.
One way to analyze functional data is to decompose variations along
nonlinear directions from a common shape, denoted as the reference curve
in this paper. Nonlinear decomposition of curves or multivariate data has
received much attention in the past twenty years. Hastie and Stuetzle
[Hastie and Stuetzle (1989)] did pioneering work in defining and computing
principal curves, which extend the linear PCA decomposition to nonlinear
directions. Methods and applications based on principal curves are devel-
oped by Chalmond and Girard [Chalmond and Girard (1999)], Dong and
McAvoy [Dong and McAvoy (1996)], etc. However, the nonlinear principal
curves that are found to explain the most variation in data may not be
interpretable, as is often true for principal components in linear PCA as
well. Izem and Kingsolver [Izem and Kingsolver (2005)] built a 3-parameter
shape invariant model that decomposes the variation in the data into prede-
termined and interpretable directions of interest. Their model describes the
growth rate of families of caterpillars as a function of temperature:
zi(tj) =wiz(wi(tj −mi)) + hi + εi,j ,(1)
where zi(tj) is the growth rate of family i at temperature tj , z is the com-
mon shape and hi, mi, wi represent the three modes of interest: vertical
shift, horizontal location and norm-preserving slope change, respectively. A
generalization of (1) is
zi(tj) =R(θi, tj) + εi,j ,(2)
where zi(tj) is a nonlinear function of time points tj and θi is the vector of
parameters that represent fixed modes of variation.
Motivated by their ideas, a model for T-waves is proposed as a combi-
nation of a reference curve and four fixed modes of variation that are of
physiological interest: uphill slope, downhill slope, horizontal location and
vertical shift. The reference curve represents the common shape of the T-
wave; an element in the data matrix X is modeled as
xitj = xi(tj) =
{√
uidiK(ui(tj −mi)) + hi + εi(tj), tj ≤mi,√
uidiK(di(tj −mi)) + hi + εi(tj), tj >mi,(3)
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Fig. 3. Four modes of variation of T-waves: uphill slope change (u), downhill slope
change (d), horizontal location (m) and vertical shift (h).
where i= 1, . . . , I , j = 1, . . . , J , K is the reference curve, the four parameters
ui, di, mi, hi represent the uphill slope, downhill slope, horizontal location
and vertical shift of the ith T wave, respectively, and εi(tj)∼N(0, σ2i ) is the
error term. In light of (2),
R(θi, tj) =
{√
uidiK(ui(tj −mi)) + hi, tj ≤mi,√
uidiK(di(tj −mi)) + hi, tj >mi,(4)
where θi = (ui, di,mi, hi). Figure 3 is a diagram of those four modes of vari-
ation.
The model in (3) has two innovations over the 3-parameter shape invari-
ant model in (1). First is the specification of a reference curve. A reference
curve represents the common shape of all curves. It is the curve from which
all the other curves are derived so that the estimated parameters of defor-
mation can be compared and analyzed. A reference curve differs from the
principal curve since the latter is mathematically defined to explain the most
variation in the data. To measure the variation of curves within a sample, a
natural choice of the reference curve is the Fre´chet mean [Fre´chet (1948)] of
the curves in this sample. The Fre´chet mean is a generalized mean on the
nonlinear manifold, therefore, it represents the common shape of the curves.
However, since the T-waves do not differ greatly in shape and location, non-
parametric methods, such as spline interpolation of the pointwise average
curve to obtain the reference curve, are effective and much less computa-
tionally intensive. (This is illustrated in Section 3.2.) The resulting curve
is also much closer in shape to the data than a polynomial-based reference
curve as used in Izem and Kingsolver (2005).
The concept of reference curve becomes crucial in a multiple sample anal-
ysis, such as a repeated measures design. A repeated measure design requires
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a single reference curve, usually a curve obtained from the baseline sample,
so that the changes in the estimated parameters reflect the changes of the
curves over time.
The second innovation is that this model is a piecewise function of the
time points, since the uphill and downhill curves of the T-wave need to be
modeled separately. This is due to the nature of the T-wave because the
physiologic causes of deformation of the rise and of the decline of the T-
wave can be quite distinct. This method also generalizes to a model with
more piecewise functions that describe distinct shape changes over different
time segments, allowing for more flexibility in modeling the overall shape.
Using the model in (3), each T-wave in a given set of T-waves can be
rewritten as a transformation along fixed modes of variation from a refer-
ence curve. Further, such a transformation can be well approximated by
four parameters representing these modes of variation. This simultaneously
achieves significant dimension reduction of the data and a parametrization
with physiological interpretations.
To estimate (3), minimize the sum of squares of the errors, that is, for
each beat i,
θˆi = argmin
θi
∑
j
(xi(tj)−R(θi, tj))2,
where R(θi, tj) is as in (4). Standard nonlinear optimization is used to esti-
mate the parameters.
For computational accuracy and efficiency, the reference curves are cen-
tered at the origin both to facilitate the comparison of the parameter es-
timates curve to curve and also to minimize interpolation error. Since the
support sets of the reference curve, K, and of X, the set of observed T-
waves, can differ due to changes in the slope parameters, the support set for
K must be extended beyond the support set of X to allow for interpolation at
the endpoints. This causes interpolation error; centering the reference curve
minimizes the change in the support set and hence reduces this error.
The multiplication factor
√
uidi in (3) also helps reduce the change in
the support set for the same slope change, and hence reduces the interpola-
tion error. Note that when ui = di, this factor reduces to ui, which can be
regarded as a norm-preserving factor.
It is important to keep in mind that the interpretation of the four param-
eters is that they represent the vertical shift, horizontal location and slope
changes of the WHOLE curve, not just any single point or small part of
the curve. They give equal weight to all the points on the curve, and thus
represent the curve better than measures that are taken from a few points
on the curve, such as QT interval.
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3.2. An illustration. A simple example illustrates how the model works.
A one-minute ECG record from the QT Database (Sel16265) with 66 beats
is shown in Figure 4. The surface plot of the T-waves of this sample shows
the T-waves “stacked” in sequence one behind the other. The color scale,
used to accentuate the “surface geography” of the 3D plot, goes from cooler
(blues) to warmer (reds) colors over the range from low to high. Beats are
“stacked” in sequence one behind the other. In order to distinguish both
the sequence and the color progression within each single T-wave, the color
has been extended downward as vertical bars of the curve color. Visually,
the common general character of these T-waves is easily described, as is the
variation among them. We apply the model and fit 66 curves based on the
reference curve that is obtained from the average of these 66 curves. Figure 5
shows the plots of the T-waves of 4 beats. The dashed lines are the reference
curve that is identical for all beats. The dotted lines are the original T-waves
and the solid lines are the fitted curves. Note that the vertical, horizontal
and slope changes are captured very well by the fitted curves.
3.3. Model robustness to marking of T-wave boundaries. Accurate de-
termination of the end of the T-wave is widely acknowledged to be difficult.
Therefore, a model that is based on T-wave morphology rather than T-wave
boundaries and that is robust to marking those boundaries has great po-
tential value. Figure 6 shows a T-wave with boundaries [a, b] marked using
standard software. Let
[a′, b′] = [a+ s, b− s],
Fig. 4. Surface plot of a sequence of T-waves of a sample ECG (the first-minute record
of Sel16265).
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Fig. 5. Original T-waves (dotted lines), reference curve (dashed lines) and fitted curves
(solid lines) for 4 beats of an ECG from the QT data base (Sel16265).
s = −12,−4,4,12 msec. As s takes increasing values from −12 msec to
+12 msec, the interval changes from the longest one [a− 12 msec, b+ 12
msec] to the shortest [a+12 msec, b− 12 msec], and the model parameters
also change. Complete minute records of nine normal subjects are used for
illustration. The robustness of the four parameter estimates is shown in
Table 1. uˆ[a,b] is the estimate of u at interval [a, b], ∆uˆ is the difference
between uˆ at interval [a+ s, b− s] and uˆ[a,b], that is, ∆uˆ= uˆ[a+s,b−s]− uˆ[a,b].
The same definitions apply to d, m and h. Indicated in the first column, each
measure, median or standard deviation, is adjusted by its scaling factor, to
be comparable across parameters. Notice that both the medians and the
standard deviations are small and are roughly of the same scale for all the
Fig. 6. Diagram of change in T-wave boundaries as a function of s; [a, b] is the T wave
interval by the standard software. s=−12,−4,+4,+12 msec (for ECG at 250 Hz).
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Table 1
Robustness of (uˆ, dˆ, mˆ, hˆ) based on complete minute records for 9 normal subjects
Interval: Longest Shortest
[a− 12, b+ 12] [a− 4, b+ 4] [a, b] [a+ 4, b− 4] [a+ 12, b− 12]
median(∆uˆ)/uˆ[a,b] 0.0048 0.0024 0 −0.0004 0.0010
stdev(∆uˆ)/uˆ[a,b] 0.0243 0.0096 0 0.0065 0.0107
median(∆dˆ)/dˆ[a,b] −0.0000 0.0009 0 0.0006 0.0002
stdev(∆dˆ)/dˆ[a,b] 0.0204 0.0079 0 0.0055 0.0119
median(∆hˆ)/hˆ[a,b] −0.0019 −0.0023 0 −0.0011 −0.0012
stdev(∆hˆ)/hˆ[a,b] 0.0059 0.0063 0 0.0055 0.0064
median(∆mˆ)/mˆ[a,b] −0.0005 −0.0000 0 −0.0000 −0.0001
stdev(∆mˆ)/mˆ[a,b] 0.0058 0.0014 0 0.0012 0.0020
median(∆mˆ) 0.0131 msec 0.0544 msec 0 −0.0395 msec −0.1684 msec
stdev(∆mˆ) 0.3723 msec 0.1825 msec 0 0.2290 msec 0.5124 msec
parameters. For parameterm, the absolute change in the unit of milliseconds
is also shown.
A plot provided courtesy of an anonymous referee shows two T-waves,
one following the placebo, the other following administration of a positive
control (amoxicillin). At hour 4, the percentage difference between uphill
slopes for placebo and amoxicillin (up and ua, respectively) is (up− ua)/up,
approximately 0.111. The downhill slope percentage difference ((dp−da)/dp)
is roughly 0.156, the vertical percentage difference is roughly 0.111, and the
horizontal percentage difference is roughly 0.083. Note that these differences
substantially exceed the magnitude of change in the parameter estimates
under different settings of the T-wave boundaries, as shown in Table 1.
Thus, the analysis of T-wave morphology is sufficiently sensitive to detect
these drug induced changes. The median and the standard deviation of ∆mˆ,
measured in milliseconds, also show that alteration of the T-wave boundaries
do not present difficulties in the horizontal location estimate, given that the
minimum critical change in the QT (cut-off value) is orders of magnitude
higher, usually 10 milliseconds.
The 24 milliseconds range for s (altering the interval length over a range
of 48 milliseconds) was chosen to establish robustness for (ui, di,mi, hi) over
a broad range for concern about QT prolongation based on FDA practice of
seriously scrutinizing prolongations in excess of 10 milliseconds.
3.4. Relation of T-wave shape to QT. Effectively, the relationship be-
tween the four parameters that describe changes in the shape of the T-wave
and changes in the QT interval is through translation and/or through flat-
tening of the T-wave. As shown in Figure 7, measurement of QT can be
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depicted by placing one beat on a plane where the baseline matches the
horizontal axis, t, and with the origin placed at the initiation of the Q-wave.
The QT interval then ends approximately where the T-wave intersects the
horizontal axis on its right. To see the relationship between the four pa-
rameters and QT, first consider their relationship to be a (less complicated)
quadratic form:
K(t) = a(t− b)2 + c, a < 0, c > 0;(5)
QT can be calculated explicitly:
QT = b+
√
− c
a
.(6)
Let K˜(t) be the quadratic function written in the form of the model in
(3),
K˜(t) =
{√
uidi[a(ui(t−mi)− b)2 + c] + hi, t≤mi,√
uidi[a(di(t−mi)− b)2 + c] + hi, t >mi.
Thus,
Q˜T =


mi +
b
ui
+
1
ui
√
− c
a
− h
a
√
uidi
, t≤mi,
mi +
b
di
+
1
di
√
− c
a
− h
a
√
uidi
, t >mi.
(7)
From (7) the dependence of QT on m is seen to be direct and positive,
while dependence on u and on d is inverse. The relationship of (h)1/2 to QT
is direct, but also involves both u and d. Therefore, when, as can occur in
practice, the data show hˆ to be correlated with uˆ and/or dˆ, the observed
QT may or may not exhibit a positive simple correlation of QT with hˆ.
Fig. 7. To quantify the relationship between QT and four parameters, the ECG of one
beat is placed on a plane where the baseline matches the horizontal axis t, and the start of
Q is placed at the origin. For convenience, QT is measured from the origin to the point
where the T-wave intersects the horizontal axis on its right.
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One example that serves as an illustration is a half-minute record (Sel103),
an arrhythmia from the QT Dataset (with QT calculated using ECGpuwave
software also available on www.physionet.org). Figure 8 shows the scatter-
plots of the parameter estimates and QT intervals. For this record, QT
dependence on mˆ is evidenced in their positive correlation (r = 0.9632),
indicating that the T-wave shifts to the right to increase QT. The nega-
tive correlation between uˆ and QT means that as the uphill curve flattens,
QT gets longer. This confirms expert qualitative statements about T-wave
changes.
4. Statistical inference. The principal objectives for a functional data
analysis approach to analyze sequential T-waves are as follows: (1) to use
information for the complete form of a T-wave, (2) to capture full infor-
mation for an extended series of beats, and (3) to define a low-dimensional
parametrization model to use in drawing statistical inferences.
Consider the problem arising in analysis of an arrhythmia: classification
of beats according to the shape of their T-waves. Clustering similar beats
in ECGs is the first step in identifying patterns of beats that characterize
specific cardiac function abnormalities. For example, if a cluster of similar
beats is defined in terms of the parameter h (and not dependent upon u, d
or m), then the types of beats differ by the T-wave heights, that is, by the
Fig. 8. Four parameter estimates versus QT (Sel103) showing correlations with mˆ (pos-
itive) and uˆ (negative).
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Fig. 9. A sample ECG for patient Sel104.
signal intensity not by its pattern. In contrast, multivariate-defined clusters
differ according to the signal patterns and possibly the signal intensity.
Figure 9 shows a sequence of the ECG tracing of an arrhythmia subject
Sel104 from the QT Dataset (a four-minute record with 292 beats). Visually
there are two major types of beats: one type with normal T-waves and
the other type with “S” shape T-waves. Figure 10 shows that neither the
beat length (RR: interval from preceding R peak to succeeding one) nor
QT successfully discriminates between these two types of beats. (Here the
QT intervals are obtained by applying ECGpuwave software followed by
confirmation or correction by expert review.)
Figure 11 shows the plots of uˆ, dˆ, mˆ and hˆ in (a), (b), (c) and (d),
respectively. Observe that both dˆ and hˆ do well in separating these two
groups. In fact, using K-means clustering for dˆ, one can get two clusters
that match (95.35% of beats) with the two groups. uˆ also does a fairly good
job, but mˆ does not distinguish the two groups.
An alternative method for modeling T-wave shape uses two Gaussians.
Approximation of a single T-wave as a mixture of two Gaussians can be quite
Fig. 10. Normal (circle) and abnormal (star) beats, plotted vs (a) RR and (b) QT.
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Fig. 11. Normal (circle) and abnormal (star) beats for a 4-minute record (292 beats) of
Sel104, plotted as time series of (a) uˆ (b) dˆ (c) mˆ and (d) hˆ.
precise [Clifford (2006)]; this can be combined with a suitable algorithm to
define the end of T-wave in terms of a specified tail probability. However,
this exercise is (independent) curve fitting to individual beats, hence is not
amenable to further statistical inference.
Figure 12 plots the means (µ1, µ2) of the left and right Gaussians fitted as
a mixture. The left Gaussian which dominates the onset of the T-wave does
not discriminate between beat types. The right Gaussian which dominates
extreme tail behavior is only partially successful, with an overall misclas-
sification rate of 26.73%. (By comparison, the overall misclassification rate
using the four-parameter model is 4.65%.) However, inferences about the
typical shape of each type of T-wave remains difficult. This is due in part
to the number of estimated parameters (6 for each beat) and in part to the
instability of the parametrization. In fact, parametrization of the Gaussian
model is not robust to small changes in T-wave shape, such as those caused
by noise. As an illustration, Figure 13 shows 2 T-waves in record Sel104.
The very slight difference in the last part of the two T-waves induces two
very different parametrizations. For the first T-wave in (a), the two Gaus-
sian functions are almost identical. The parametrization (λi, σ
2
i , µi), where
λi is the unnormalized mixing coefficient for the ith Gaussian, is (4.5102,
19.5607, 44.4245) for the first Gaussian and (4.5102, 19.5588, 44.4265) for
the second Gaussian; and the two Gaussian curves are seen to overlap in
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Fig. 12. Normal (circle) and abnormal (star) beats, plotted vs (a) the first location pa-
rameter µ1 of a Gaussian model and (b) the second location parameter µ2 of a Gaussian
model.
Figure 13(a), while for the second T-wave in (b) the two sets of parameters
are quite different: (3.3558, 11.0680, 27.8644) and (6.9715, 18.7290, 55.7295),
and the Gaussians separate as shown in Figure 13(b). Thus, the parameters
for the Gaussian model cannot accurately reflect the degree of difference
among curves, and hence do not make a good biomarker for analysis of
T-wave shape or statistical inference about beat problems.
There are other methods that work well in classifying curves, such as
wavelet-based methods [Wang, Ray and Mallick (2007)], or even PCA; but
neither wavelet coefficients nor principal components of the curves help to
understand the physiological change in the shape of the T-wave. From the se-
quences of four parameter estimates one can obtain more information about
the different shape of the T-wave for different groups. For example, by in-
specting Figure 11, one observes that, among the two groups, one group has
higher uˆ (greater than 1), lower dˆ (less than 1), lower hˆ and similar mˆ as
the other. Note that for uˆ and dˆ, 1 is a cut-off value because when uˆ > 1,
the uphill curve is steeper than the reference curve, elsewhere it is flatter.
The same applies to dˆ. So it can be imagined that one group of beats has
steeper uphill curve, flatter downhill curve and lower height than the refer-
ence curve. The other group behaves conversely. The horizontal positions do
not distinguish the two. These descriptions match the true curves as shown
in Figure 14.
Furthermore, one can obtain information about T-wave shape change by
studying the parameter estimates over beats as four time series. To study
the frequency components of these time series, one can obtain the power
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Fig. 13. Two similar T-waves (solid lines) in record Sel104, with two Gaussian functions
(dashed lines and dotted lines) fitted to each by the Gaussian model.
spectral density, shown in Figure 15. Note that uˆ, dˆ and hˆ all have peaks at
0.1265 Hz, 0.1429 Hz and 0.1592 Hz, corresponding to periods 7.9 sec (9.6
beats), 7 sec (8.51 beats) and 6.28 sec (7.64 beats). These are roughly the
frequencies of the abnormal beats that can be observed from the ECG chart.
mˆ has a peak at 0.1674 Hz, corresponding to 5.97 sec (7.2 beats). Since mˆ
is most correlated with RR among the four parameters (see Figure 16), and
regular changes in RR are usually related to breathing, a reasonable guess
Fig. 14. The reference curve and typical curves of the two types of T-waves in Sel104.
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Fig. 15. The power spectral density of uˆ, dˆ, mˆ and hˆ.
is that this frequency reflects the breathing pattern of this subject. Many
other properties in the time domain and frequency domain can be studied
as well.
In order to make comparisons between time segments or between exper-
imental conditions, the QT measure needs to be adjusted by the RR (the
inverse of the heart rate) because of the relationship long-recognized be-
tween the two. Although the literature on choices of adjustment function
is extensive, no consensus has been reached on the optimal “correction” or
adjustment function. This may be at least partially attributable to the dis-
parity in changes in the QT and in the TQ intervals with change in RR,
especially in normal subjects. Adjustment methods for the four-parameter
model will depend on the direct relationship of the T-wave shape and RR;
and this relationship may differ between normal subjects or among subjects
with different known arrhythmias. Also, the dependence between RR and
the onset of T-wave shape alteration may exhibit a lag of several beats.
The first example, shown in Figure 16, is a four-minute record of an ar-
rhythmia subject Sel103 from the QT Dataset. Here uˆ and RR are modestly
negatively correlated, which means that as uphill curve gets flatter, RR gets
longer. The positive correlation of mˆ and RR means that the RR prolonga-
tion is generally related to a T-wave shift to the right. Relationships of dˆ and
hˆ with RR are not apparent in this record. This data set benefits from a mul-
tivariate clustering approach since several individual relationships between
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Fig. 16. Correlations of four parameter estimates with RR (Sel103).
model parameter estimates and RR are accompanied by interdependencies
among the parameters. Further analysis shows that uˆ and dˆ are negatively
correlated in this case, that is, the uphill curve and downhill curve change
their slopes in such a way as to keep the angle between them relatively
stable.
Different arrhythmias exhibit different patterns and may arise from dif-
ferent causes; the four-parameter model enables inferences about these pat-
terns. A second example illustrates a different phenomenon. In this arrhyth-
mia, the sequence of beats can be shown to have an approximate period-
icity. By representing this record as a series of four-dimensional vectors
(uˆ, dˆ, mˆ, hˆ)′, the lag of principal time-dependency can be established. Ta-
ble 2 shows the correlation of each parameter at time t with RR at time t,
t− 1, t− 2 and t− 3 for the 2nd minute of the record of Sel123 from the QT
Dataset. Note that all the parameters are most strongly correlated with RR
at (t− 2), indicating a two-beat lag between RR and the altered T-wave.
Thus, a longer beat is followed by alteration in the T-wave form (shallower).
Physiologically this may have explanation in terms of energy expenditure
and the adequacy of the “rest” between the end of the T-wave and the onset
of the subsequent P-wave. The last row indicates that QT does not capture
such a phenomenon.
5. Discussion. Besides the applications mentioned in Section 4, there
are others such as outlier beat detection and discrimination between normal
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Table 2
Correlation between the estimated model
parameters and current and previous RRs
RR t t− 1 t− 2 t− 3
uˆ −0.3216 −0.4003 −0.7554 −0.3152
dˆ −0.4580 −0.6309 −0.7428 −0.3957
mˆ 0.3009 0.3419 0.4596 0.1900
hˆ 0.2410 −0.1825 −0.3977 0.0605
QT −0.0478 0.1953 0.1646 −0.0455
subjects and arrhythmia subjects. One can detect outlier beats by treating
the four parameters’ values as four-dimensional vector data and applying
standard outlier detection methods for multivariate data. Distinguishing ar-
rhythmias from normal heart rhythms can be done based on the patterns
of variation in this four-dimensional characterization. Work is ongoing to
develop specific methodology to encompass beat classification and analysis
of the temporal process.
Methods for analyzing data with a general data structure described in Sec-
tion 2.2 depend on the purpose of the study. For the measurement of T-wave
variation within each sample, for example, detection of outlier beats within
a record, the reference curve can be computed as the pointwise average curve
for the record, and the analysis is based on the parameter estimates for the
curves in that record. For multiple records of the same subject, a “super-
reference curve” can be computed, by analogy to MANOVA methodology,
the parameter estimates using the within-record reference curve and those
computed using the super-reference curve can be analyzed. (This approach
inherits the same problems of unequal variances and unequal sample sizes
that are present in MANOVA analyses with essentially the same solutions.)
For complex experiment designs with ECGs taken repeatedly over time
and/or under varying conditions, the actual time courses of T-wave changes
as well as variation may be the primary focus. (For example, in a study of a
new drug, ECGs may be conducted for each subject at a dozen time points
each day beginning with a baseline—none, placebo, positive control sub-
stance, drug, etc.) In such a case the reference curves for individual records
within each set form a data set of curves to be studied. Once again, apply-
ing a functional analysis approach, a hyper-reference curve can be computed
(from the record reference curves) and analyzed.
The functional data approach used here could also be extended to alter-
native choices of the reference curve. For example, robust methods could be
applied to reduce the influence of outlier beats. In the case when there are
clusters of beats varying by shape, such as in Figure 9, this approach may
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first be applied to cluster beats, as described in Section 4, then it is applied
within each cluster to capture the individual differences within the cluster.
Extension of the method proposed here to multi-lead ECG data is direct.
Standard 12- or 16-lead ECGs provide spatial information about the heart
as well as redundancies and “check information.” Current work combines
dimension reduction methods with this functional data modeling approach
to more fully incorporate the information from multiple leads without de-
creasing the signal-to-noise ratio. In addition, since specific leads measure
the electrical potential across different parts of the heart, the extension to
a higher dimensional model should lead to a more general methodology and
increase sensitivity to other aberrant cardiac behaviors.
6. Conclusion. In this paper functional data analysis is used to construct
a statistical model of ECG T-waves. This model makes the physiologically
reasonable assumption that there is a common primary shape (within sub-
ject) for the T-waves and it uses four interpretable parameters to describe
the individual deviation of each beat from the common T-wave shape. The
model accounts for the entire T-wave morphology, making the estimation
robust to the marking of T-wave boundaries. Applications such as classifi-
cation of beats were illustrated for this model. Application of this model to
measuring drug-induced change in T-wave is intended, pending availability
of control ECGs from actual QT studies.
Note: Programs in matlab to implement the method are available from
the authors. Please send requests by email to yingchun z@yahoo.com.
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